Geoffrey W. Smith

Geoff is the founder and Managing Partner of Digitalis. He currently represents Digitalis as a Director of CareDox Inc. and as a Board Observer of Second Genome, Inc.

He is also a co-founder and General Partner of Ascent Biomedical Ventures, a New York City-based venture capital firm focused on early-stage life sciences investments.  Geoff currently represents Ascent on the Board of Directors for Azevan Pharmaceuticals, BackBeat Medical, BlinkBio, and Caliber Therapeutics, and is a Board Observer of Vivasure Medical. 

Geoff is a co-founder of Fuse Therapeutics. He is also a Visiting Scholar at Rockefeller University and an adjunct faculty member at the RU Center for Clinical and Translational Science. He is also a member of the Scientific Advisory Board for Brigham & Women’s Hospital in Boston. Previously, he was the founding Director of the Mount Sinai Institute of Technology and a Professor in the Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai. 

Geoff received a B.A. (with honors) from Williams College and a J.D. from the University of Pennsylvania Law School.